📰 Mcdaniel Terry News
Page 4 - Mcdaniel Terry News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mcdaniel Terry. Real-time updates on events, politics, business and more.
October 16, 2023
Koss Olinger Consulting LLC reduced its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 16.4% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 3,592 shares of the biopharmaceutical company’s stock after selling 704 shares during the quarter. Koss Olinger Consulting LLC’s holdings in […]
October 14, 2023
Independent Advisor Alliance lowered its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 0.7% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 39,610 shares of the biopharmaceutical company’s stock after selling 284 shares during the period. Independent Advisor […]
October 13, 2023
Cantor Fitzgerald restated their overweight rating on shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) in a research note issued to investors on Monday morning, Benzinga reports. They currently have a $75.00 target price on the biopharmaceutical company’s stock. A number of other equities research analysts have also recently issued reports on BMY. TD Cowen […]
October 13, 2023
Invst LLC grew its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 6.4% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 4,839 shares of the biopharmaceutical company’s stock after purchasing an additional 289 shares during the period. Invst LLC’s holdings in Bristol-Myers Squibb were […]
October 11, 2023
Inlet Private Wealth LLC lifted its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 1.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 64,502 shares of the biopharmaceutical company’s stock after acquiring an additional 875 shares during the quarter. Bristol-Myers Squibb […]
October 7, 2023
Mcdaniel Terry & Co. boosted its holdings in shares of Exxon Mobil Co. (NYSE:XOM – Free Report) by 1.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 50,263 shares of the oil and gas company’s stock after acquiring an […]
October 4, 2023
Mcdaniel Terry & Co. cut its stake in PepsiCo, Inc. (NASDAQ:PEP – Free Report) by 1.2% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 171,326 shares of the company’s stock after selling 2,122 shares during the period. PepsiCo accounts for about 3.2% […]
October 3, 2023
Mcdaniel Terry & Co. purchased a new position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 436 shares of the company’s stock, valued at approximately $204,000. Other hedge funds and other institutional […]
October 3, 2023
Mcdaniel Terry & Co. boosted its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 4.5% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,915 shares of the biopharmaceutical company’s stock after purchasing an additional 300 shares during […]
October 3, 2023
Mcdaniel Terry & Co. reduced its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.3% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 17,398 shares of the healthcare product maker’s stock after selling 227 shares during the […]